Results 361 to 370 of about 629,305 (401)
Some of the next articles are maybe not open access.

▼ Indacaterol for COPD

Drug and Therapeutics Bulletin, 2012
▼Indacaterol powder for inhalation (Onbrez Breezhaler – Novartis) is a long-acting beta2 agonist, licensed for once-daily use as maintenance bronchodilator therapy for chronic obstructive pulmonary disease (COPD). In this article, we consider the evidence for indacaterol and how its use fits with current management strategies for COPD.
openaire   +2 more sources

Asthma and COPD

Experimental and Toxicologic Pathology, 2006
The two obstructive airway diseases bronchial asthma and chronic obstructive pulmonary disease (COPD) represent major global causes of disability and death, and COPD is estimated to become the third most common cause of death by 2020. The structural and pathophysiologic findings in both diseases appear to be easily differentiated in the extremes of ...
Tobias, Welte, David A, Groneberg
openaire   +2 more sources

Sexuality and COPD

Rehabilitation Nursing, 1989
Persons with chronic obstructive pulmonary disease (COPD) who wish to remain sexually active must make adaptations to compensate for their diminishing activity tolerance, increasing dyspnea, role and sexual self-image changes, anxiety, and increased need for communication.
openaire   +2 more sources

COPD rehabilitation

Wiener Medizinische Wochenschrift, 2005
Rehabilitation of COPD-patients is an important part of the therapeutic management. The effects of endurance- and resistance-training as well as respiratory muscle-training are evident. Smoking cessation therapy is standardized, effective and cheap, and is the prerequisite of a successful COPD management.
Hartmut, Zwick, Alfred, Lichtenschopf
openaire   +2 more sources

Exacerbations of COPD

Respiratory Care, 2023
COPD exacerbations are associated with significant morbidity, mortality, and increased health care expenditures. The recently published Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations have further refined the definition of an exacerbation.
openaire   +2 more sources

The pathobiology of COPD

Wiener Medizinische Wochenschrift, 2005
Chronic obstructive pulmonary disease (COPD) is characterised by a chronic inflammation in the pulmonary tissue. The disease is associated with a switch from a self-limiting inflammatory response, mainly initiated by smoke inhalation, to a chronic persistent inflammatory response after prolonged interaction with cigarette smoke.
openaire   +2 more sources

Pathogenesis of COPD

Clinical Cornerstone, 2003
Chronic obstructive pulmonary disease (COPD) is not a single disorder. Rather, it is a collection of disorders characterized by the progressive development of airflow limitation. Patients afflicted with COPD experience systemic effects that are often responsible for major clinical problems.
openaire   +2 more sources

▼Glycopyrronium for COPD

Drug and Therapeutics Bulletin, 2013
▼Glycopyrronium powder for inhalation (Seebri Breezhaler—Novartis) is a long-acting muscarinic receptor antagonist (LAMA), licensed as a maintenance bronchodilator treatment to relieve symptoms in adults with chronic obstructive pulmonary disease (COPD).1 This is the third long-acting agent that has recently been licensed in the UK for use in people ...
openaire   +2 more sources

Pathogenesis of COPD

Seminars in Respiratory and Critical Care Medicine, 2005
Chronic obstructive pulmonary disease (COPD) is characterized and defined by limitation of expiratory airflow. This can result from several types of anatomical lesions, including loss of lung elastic recoil and fibrosis and narrowing of small airways. Inflammation, edema, and secretions also contribute variably to airflow limitation.
John R, Spurzem, Stephen I, Rennard
openaire   +2 more sources

COPD in the chromosomes

Thorax, 2022
Beatrice Cockbain   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy